Axcelis Announces Financial Results For First Quarter 2014
- Net income of
$0.2 million or$0.00 per share compared to net income of$0.6 million or$0.01 per share in the fourth quarter of 2013. - System sales of
$32.5 million , a 27% increase over the fourth quarter of 2013, reflecting market acceptance of the Purion™ platform. - Closed an order for the Company's innovative Purion M™ medium current implanter with a second leading chipmaker in
Asia after a highly successful evaluation process in which the product exceeded goals in numerous performance categories. - Shipped multiple Purion XE™ implanters for high volume production of advanced NAND devices.
The Company reported first quarter revenue of
Chairman and CEO
First Quarter 2014 Conference Call
The Company will host a conference call today at
Safe Harbor Statement
The conference call will contain forward-looking statements under the
About
Company Contacts
Investor Relations:
978.787.9552
Editorial/Media:
978.787.4266
Axcelis Technologies, Inc. |
||||||
Three months ended March 31, |
||||||
2014 |
2013 |
|||||
Revenue |
||||||
Product |
$55,015 |
$34,452 |
||||
Services |
5,825 |
6,274 |
||||
Total revenue |
60,840 |
40,726 |
||||
Cost of revenue |
||||||
Product |
33,802 |
22,181 |
||||
Services |
5,298 |
5,602 |
||||
Total cost of revenue |
39,100 |
27,783 |
||||
Gross profit |
21,740 |
12,943 |
||||
Operating expenses |
||||||
Research and development |
9,257 |
9,206 |
||||
Sales and marketing |
5,476 |
5,201 |
||||
General and administrative |
6,481 |
6,590 |
||||
Gain on sale of dry strip assets and intellectual property |
- |
(368) |
||||
Restructuring charges |
200 |
1,801 |
||||
Total operating expenses |
21,414 |
22,430 |
||||
Income (loss) from operations |
326 |
(9,487) |
||||
Other income (expense) |
||||||
Interest income |
2 |
3 |
||||
Interest expense |
(251) |
- |
||||
Other, net |
292 |
829 |
||||
Total other income |
43 |
832 |
||||
Income (loss) before income taxes |
369 |
(8,655) |
||||
Income taxes |
195 |
333 |
||||
Net income (loss) |
$174 |
$(8,988) |
||||
Net earnings (loss) per share |
||||||
Basic |
$0.00 |
$(0.08) |
||||
Diluted |
$0.00 |
$(0.08) |
||||
Shares used in computing net earnings (loss) per share |
||||||
Basic weighted average common shares |
110,649 |
108,227 |
||||
Diluted weighted average common shares |
115,798 |
108,227 |
||||
Axcelis Technologies, Inc. |
|||||||
March 31, |
December 31, |
||||||
ASSETS |
|||||||
Current assets |
|||||||
Cash and cash equivalents |
$ |
43,039 |
$ |
46,290 |
|||
Accounts receivable, net |
38,121 |
36,587 |
|||||
Inventories, net |
95,533 |
95,789 |
|||||
Prepaid expenses and other current assets |
7,476 |
6,242 |
|||||
Total current assets |
184,169 |
184,908 |
|||||
Property, plant and equipment, net |
31,605 |
32,006 |
|||||
Restricted cash, long-term |
825 |
825 |
|||||
Other assets |
16,104 |
15,810 |
|||||
Total assets |
$ |
232,703 |
$ |
233,549 |
|||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
Current liabilities |
|||||||
Accounts payable |
$ |
17,865 |
$ |
19,451 |
|||
Accrued compensation |
4,692 |
4,845 |
|||||
Warranty |
1,496 |
1,316 |
|||||
Income taxes |
474 |
417 |
|||||
Deferred revenue |
3,836 |
4,387 |
|||||
Current portion of long-term debt |
762 |
471 |
|||||
Other current liabilities |
4,100 |
4,573 |
|||||
Total current liabilities |
33,225 |
35,460 |
|||||
Long-term debt |
14,238 |
14,529 |
|||||
Long-term deferred revenue |
257 |
322 |
|||||
Other long-term liabilities |
7,058 |
7,236 |
|||||
Total liabilities |
54,778 |
57,547 |
|||||
Commitments and contingencies |
|||||||
Stockholders' equity |
|||||||
Preferred stock, $0.001 par value, 30,000 shares authorized; none issued or outstanding |
— |
— |
|||||
Common stock, $0.001 par value, 300,000 shares authorized; 111,269 shares issued and 111,149 shares outstanding at March 31, 2014;110,225 shares issued and 110,105 shares outstanding at December 31, 2013 |
111 |
110 |
|||||
Additional paid-in capital |
513,411 |
510,992 |
|||||
Treasury stock, at cost, 120 shares at March 31, 2014 and December 31, 2013 |
(1,218) |
(1,218) |
|||||
Accumulated deficit |
(339,447) |
(339,621) |
|||||
Accumulated other comprehensive income |
5,068 |
5,739 |
|||||
Total stockholders' equity |
177,925 |
176,002 |
|||||
Total liabilities and stockholders' equity |
$ |
232,703 |
$ |
233,549 |
|||
Axcelis Technologies, Inc. |
||||||||
Three months ended |
||||||||
March 31, |
||||||||
2014 |
2013 |
|||||||
Cash flows from operating activities |
||||||||
Net income (loss) |
$ 174 |
$ (8,988) |
||||||
Adjustments to reconcile net income (loss) to net cash used for operating activities: |
||||||||
Depreciation and amortization |
1,140 |
1,394 |
||||||
Gain on sale of dry strip assets and intellectual property |
- |
(368) |
||||||
Deferred taxes |
312 |
56 |
||||||
Stock-based compensation expense |
1,172 |
839 |
||||||
Provision for excess inventory |
59 |
2,211 |
||||||
Changes in operating assets & liabilities |
||||||||
Accounts receivable |
(1,634) |
1,458 |
||||||
Inventories |
(52) |
(1,672) |
||||||
Prepaid expenses and other current assets |
(1,252) |
(544) |
||||||
Accounts payable and other current liabilities |
(2,025) |
5,043 |
||||||
Deferred revenue |
(614) |
(843) |
||||||
Income taxes |
61 |
84 |
||||||
Other assets and liabilities |
(1,304) |
(549) |
||||||
Net cash used for operating activities |
(3,963) |
(1,879) |
||||||
Cash flows from investing activities |
||||||||
Proceeds from sale of dry strip assets and intellectual property |
- |
400 |
||||||
Expenditures for property, plant, and equipment |
(227) |
(150) |
||||||
Decrease in restricted cash |
- |
3 |
||||||
Net cash (used for) provided by investing activities |
(227) |
253 |
||||||
Cash flows from financing activities |
||||||||
Proceeds from exercise of stock options |
1,277 |
49 |
||||||
Net cash provided by financing activities |
1,277 |
49 |
||||||
Effect of exchange rate changes on cash |
(338) |
(968) |
||||||
Net decrease in cash and cash equivalents |
(3,251) |
(2,545) |
||||||
Cash and cash equivalents at beginning of period |
46,290 |
44,986 |
||||||
Cash and cash equivalents at end of period |
$43,039 |
$ 42,441 |
Logo - http://photos.prnewswire.com/prnh/20130905/NE75070LOGO
SOURCE